Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2017-12-14 | 2018-02-15 | 32813 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-10-31 | 2024-11-15 | 241694 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-10-27 | 2023-12-01 | 208388 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209954 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-23 | 2023-08-04 | 196315 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-09-09 | 2022-12-05 | 169054 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2018-05-31 | 2018-10-05 | 50956 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2019-01-15 | 2020-04-07 | 72357 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-29 | 2023-08-04 | 196952 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-03-13 | 2019-05-06 | 78529 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-09-18 | 2019-11-25 | 94171 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-03-16 | 2023-03-30 | 187241 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223058 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-10-11 | 2018-10-16 | 63793 |
| APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2019-11-20 | 2020-04-07 | 99311 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2023-09-07 | 2023-10-15 | 203825 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-08-09 | 2018-10-16 | 57792 |
| APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2022-06-06 | 2022-09-06 | 162094 |
| APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Actual shortage | 2025-03-20 | 2025-05-22 | 253064 |
| APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2023-08-18 | 2023-12-01 | 202397 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |